OTC Pharmaceuticals in Russia

OTC Pharmaceuticals in Russia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Scope

Essential resource for top-line data and analysis covering the Russia otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Reasons to buy

_x005F What was the size of the Russia otc pharmaceuticals market by value in 2015

_x005F What will be the size of the Russia otc pharmaceuticals market in 2020

_x005F What factors are affecting the strength of competition in the Russia otc pharmaceuticals market

_x005F How has the market performed over the last five years

_x005F Who are the top competitors in Russia's otc pharmaceuticals market

Companies mentioned

JSC ELFA

The Menarini Group

Pharmstandard OJSC

Sanofi SA

Table of Contents

Executive Summary

Market value

Market value forecast

Category segmentation

Geography segmentation

Market share

Market rivalry

Market Overview

Market definition

Market analysis

Market Data

Market value

Market Segmentation

Category segmentation

Geography segmentation

Market share

Market distribution

Market Outlook

Market value forecast

Five Forces Analysis

Summary

Buyer power

Supplier power

New entrants

Threat of substitutes

Degree of rivalry

Leading Companies

JSC ELFA

The Menarini Group

Pharmstandard OJSC

Sanofi SA

Macroeconomic Indicators

Country data

Methodology

Industry associations

Related MarketLine research

Appendix

About MarketLine

List of Tables

Table 1: Russia OTC pharmaceuticals market value: $ million, 201115

Table 2: Russia OTC pharmaceuticals market category segmentation: $ million, 2015

Table 3: Russia OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 4: Russia OTC pharmaceuticals market share: % share, by value, 2015

Table 5: Russia OTC pharmaceuticals market distribution: % share, by value, 2015

Table 6: Russia OTC pharmaceuticals market value forecast: $ million, 201520

Table 7: JSC ELFA: key facts

Table 8: The Menarini Group: key facts

Table 9: The Menarini Group: key financials ($)

Table 10: The Menarini Group: key financials (€)

Table 11: The Menarini Group: key financial ratios

Table 12: Pharmstandard OJSC: key facts

Table 13: Pharmstandard OJSC: key financials ($)

Table 14: Pharmstandard OJSC: key financials (RUB)

Table 15: Pharmstandard OJSC: key financial ratios

Table 16: Sanofi SA: key facts

Table 17: Sanofi SA: key financials ($)

Table 18: Sanofi SA: key financials (€)

Table 19: Sanofi SA: key financial ratios

Table 20: Russia size of population (million), 201115

Table 21: Russia gdp (constant 2005 prices, $ billion), 201115

Table 22: Russia gdp (current prices, $ billion), 201115

Table 23: Russia inflation, 201115

Table 24: Russia consumer price index (absolute), 201115

Table 25: Russia exchange rate, 201115

List of Figures

Figure 1: Russia OTC pharmaceuticals market value: $ million, 201115

Figure 2: Russia OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 3: Russia OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 4: Russia OTC pharmaceuticals market share: % share, by value, 2015

Figure 5: Russia OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 6: Russia OTC pharmaceuticals market value forecast: $ million, 201520

Figure 7: Forces driving competition in the OTC pharmaceuticals market in Russia, 2015

Figure 8: Drivers of buyer power in the OTC pharmaceuticals market in Russia, 2015

Figure 9: Drivers of supplier power in the OTC pharmaceuticals market in Russia, 2015

Figure 10: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Russia, 2015

Figure 11: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Russia, 2015

Figure 12: Drivers of degree of rivalry in the OTC pharmaceuticals market in Russia, 2015

Figure 13: Pharmstandard OJSC: revenues & profitability

Figure 14: Pharmstandard OJSC: assets & liabilities

Figure 15: Sanofi SA: revenues & profitability

Figure 16: Sanofi SA: assets & liabilities

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports